Home
Drucken
Falk Foundation | Dr. Falk
Sie befinden sich hier:  Home
Press releases from recent symposias
Liver and Bowel Diseases: Incorporating Therapeutic Progress into Clinical Routines
 
Symposium 205, Lucerne (Switzerland), October 2016
 
Lucerne. Progress is currently being made in treating both chronic liver and chronic bowel disease. This is not only the case for hepatitis C, but now also for cholestatic liver diseases and inflammatory bowel disease (IBD). However, the novel therapy options are now making treatment considerably more complex, highlighted Professor Gerhard Rogler, Zürich... More...

Liver experts are working on new diagnostic and therapeutic tools

 
Symposium 204, Birmingham (United Kingdom), September 2016
 
Birmingham. Globally, every year more than 2 million people die from complications of chronic liver disease. Hepatitis, autoimmune diseases, the consequences of overnutrition, and alcohol abuse were the subjects of an international symposium held by the Falk Foundation e.V. in Birmingham/United Kingdom. More...

XXIV International Bile Acid Meeting Düsseldorf: Bile Acids in Health and Disease
  
Symposium 203, Düsseldorf (Germany), June 2016
  
Düsseldorf. The importance of bile acids and bile acid derivatives as signal transmitters in numerous (patho-)physiological processes and their potential in the treatment of hepatobiliary disorders are becoming clearer and clearer.  More...
Symposia Overview
All
symposia






More...
GastroScope
Symposium 202
Evolving Therapies in
Clinical Practice in IBD

Prague (Czech Republic),
April 29 – 30, 2016



More...
News
 
 Workshop
 Essen (Germany)
 January 21 - 22, 2017




 More...
Video Report
Treating PBC and PSC
Prof. Dr. U. Beuers, Amsterdam,
Symposium 201
„Gut-Liver
Interactions: From
IBD to NASH“

More...